EW Annual Operating Expenses
$2.90 B
+$383.50 M+15.27%
31 December 2023
Summary:
As of January 22, 2025, EW annual total operating expenses is $2.90 billion, with the most recent change of +$383.50 million (+15.27%) on December 31, 2023. During the last 3 years, it has risen by +$906.10 million (+45.55%). EW annual operating expenses is now at all-time high.EW Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Quarterly Operating Expenses
$697.20 M
-$26.20 M-3.62%
30 September 2024
Summary:
As of January 22, 2025, EW quarterly total operating expenses is $697.20 million, with the most recent change of -$26.20 million (-3.62%) on September 30, 2024. Over the past year, it has dropped by -$12.70 million (-1.79%). EW quarterly operating expenses is now -10.03% below its all-time high of $774.90 million, reached on March 31, 2024.EW Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.3% | -1.8% |
| 3 y3 years | +45.5% | +15.7% |
| 5 y5 years | +69.2% | +39.0% |
EW Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.8% | -10.0% | +16.4% |
| 5 y | 5-year | at high | +45.5% | -10.0% | +52.6% |
| alltime | all time | at high | +912.3% | -10.0% | +2398.9% |
Edwards Lifesciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $697.20 M(-3.6%) |
| June 2024 | - | $723.40 M(-6.6%) |
| Mar 2024 | - | $774.90 M(+3.3%) |
| Dec 2023 | $2.90 B(+15.3%) | $750.00 M(+5.6%) |
| Sept 2023 | - | $709.90 M(+8.5%) |
| June 2023 | - | $654.10 M(-6.2%) |
| Mar 2023 | - | $697.50 M(+8.4%) |
| Dec 2022 | $2.51 B(+4.8%) | $643.20 M(+5.3%) |
| Sept 2022 | - | $610.90 M(-7.4%) |
| June 2022 | - | $659.80 M(+10.2%) |
| Mar 2022 | - | $598.90 M(-8.8%) |
| Dec 2021 | $2.40 B(+20.5%) | $656.80 M(+9.0%) |
| Sept 2021 | - | $602.40 M(+0.4%) |
| June 2021 | - | $599.80 M(+11.5%) |
| Mar 2021 | - | $537.80 M(+0.7%) |
| Dec 2020 | $1.99 B(-0.3%) | $534.20 M(+6.3%) |
| Sept 2020 | - | $502.70 M(+10.0%) |
| June 2020 | - | $457.00 M(-7.7%) |
| Mar 2020 | - | $495.20 M(-8.5%) |
| Dec 2019 | $1.99 B(+16.6%) | $541.10 M(+7.9%) |
| Sept 2019 | - | $501.70 M(+0.3%) |
| June 2019 | - | $500.40 M(+10.8%) |
| Mar 2019 | - | $451.70 M(+0.1%) |
| Dec 2018 | $1.71 B(+10.8%) | $451.20 M(+4.6%) |
| Sept 2018 | - | $431.30 M(+0.5%) |
| June 2018 | - | $429.00 M(+7.5%) |
| Mar 2018 | - | $399.20 M(-4.8%) |
| Dec 2017 | $1.54 B(+11.8%) | $419.40 M(+8.2%) |
| Sept 2017 | - | $387.50 M(+2.3%) |
| June 2017 | - | $378.90 M(+5.7%) |
| Mar 2017 | - | $358.30 M(+2.8%) |
| Dec 2016 | $1.38 B(+12.0%) | $348.50 M(+1.7%) |
| Sept 2016 | - | $342.60 M(-8.8%) |
| June 2016 | - | $375.80 M(+19.5%) |
| Mar 2016 | - | $314.50 M(-1.8%) |
| Dec 2015 | $1.23 B(+1.6%) | $320.30 M(+2.3%) |
| Sept 2015 | - | $313.00 M(+0.5%) |
| June 2015 | - | $311.40 M(+7.8%) |
| Mar 2015 | - | $288.90 M(-9.0%) |
| Dec 2014 | $1.21 B(+15.0%) | $317.30 M(+2.4%) |
| Sept 2014 | - | $309.80 M(+1.7%) |
| June 2014 | - | $304.60 M(+7.6%) |
| Mar 2014 | - | $283.00 M(+6.7%) |
| Dec 2013 | $1.06 B(+6.8%) | $265.20 M(+1.3%) |
| Sept 2013 | - | $261.90 M(-1.9%) |
| June 2013 | - | $267.10 M(+1.9%) |
| Mar 2013 | - | $262.20 M(+7.1%) |
| Dec 2012 | $988.70 M | $244.90 M(+1.4%) |
| Sept 2012 | - | $241.60 M(-5.8%) |
| June 2012 | - | $256.40 M(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $245.80 M(+9.7%) |
| Dec 2011 | $888.70 M(+17.8%) | $224.10 M(-1.4%) |
| Sept 2011 | - | $227.20 M(-0.4%) |
| June 2011 | - | $228.10 M(+9.0%) |
| Mar 2011 | - | $209.30 M(+5.5%) |
| Dec 2010 | $754.40 M(+10.2%) | $198.30 M(+6.8%) |
| Sept 2010 | - | $185.70 M(-2.9%) |
| June 2010 | - | $191.20 M(+6.7%) |
| Mar 2010 | - | $179.20 M(-0.8%) |
| Dec 2009 | $684.30 M(+10.4%) | $180.60 M(+5.7%) |
| Sept 2009 | - | $170.80 M(-0.2%) |
| June 2009 | - | $171.10 M(+5.7%) |
| Mar 2009 | - | $161.80 M(+3.7%) |
| Dec 2008 | $619.80 M(+14.7%) | $156.00 M(+1.0%) |
| Sept 2008 | - | $154.40 M(-4.6%) |
| June 2008 | - | $161.90 M(+9.8%) |
| Mar 2008 | - | $147.50 M(-0.3%) |
| Dec 2007 | $540.30 M(+10.2%) | $148.00 M(+10.4%) |
| Sept 2007 | - | $134.10 M(+2.5%) |
| June 2007 | - | $130.80 M(+3.6%) |
| Mar 2007 | - | $126.30 M(+1.0%) |
| Dec 2006 | $490.20 M(+9.4%) | $125.10 M(+4.4%) |
| Sept 2006 | - | $119.80 M(-4.8%) |
| June 2006 | - | $125.90 M(+28.5%) |
| Mar 2006 | - | $98.00 M(-13.4%) |
| Dec 2005 | $448.00 M(+10.1%) | $113.20 M(+3.0%) |
| Sept 2005 | - | $109.90 M(-3.8%) |
| June 2005 | - | $114.30 M(+3.6%) |
| Mar 2005 | - | $110.30 M(+4.0%) |
| Dec 2004 | $406.90 M(+12.2%) | $106.10 M(+4.4%) |
| Sept 2004 | - | $101.60 M(-0.1%) |
| June 2004 | - | $101.70 M(-9.9%) |
| Mar 2004 | - | $112.90 M(+23.8%) |
| Dec 2003 | $362.70 M(+2.8%) | $91.20 M(+4.5%) |
| Sept 2003 | - | $87.30 M(-10.1%) |
| June 2003 | - | $97.10 M(+7.4%) |
| Mar 2003 | - | $90.40 M(+4.6%) |
| Dec 2002 | $352.80 M(+2.6%) | $86.40 M(-36.8%) |
| Sept 2002 | - | $136.80 M(+103.3%) |
| June 2002 | - | $67.30 M(+8.0%) |
| Mar 2002 | - | $62.30 M(-3.7%) |
| Dec 2001 | $344.00 M(+20.3%) | $64.70 M(+7.7%) |
| Sept 2001 | - | $60.10 M(-60.1%) |
| June 2001 | - | $150.50 M(+119.1%) |
| Mar 2001 | - | $68.70 M(+146.2%) |
| Dec 2000 | $286.00 M(-11.2%) | $27.90 M(-62.8%) |
| Sept 2000 | - | $74.90 M(-22.0%) |
| June 2000 | - | $96.00 M(+1.1%) |
| Mar 2000 | - | $95.00 M |
| Dec 1999 | $322.00 M | - |
FAQ
- What is Edwards Lifesciences annual total operating expenses?
- What is the all time high annual operating expenses for Edwards Lifesciences?
- What is Edwards Lifesciences annual operating expenses year-on-year change?
- What is Edwards Lifesciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly operating expenses year-on-year change?
What is Edwards Lifesciences annual total operating expenses?
The current annual operating expenses of EW is $2.90 B
What is the all time high annual operating expenses for Edwards Lifesciences?
Edwards Lifesciences all-time high annual total operating expenses is $2.90 B
What is Edwards Lifesciences annual operating expenses year-on-year change?
Over the past year, EW annual total operating expenses has changed by +$383.50 M (+15.27%)
What is Edwards Lifesciences quarterly total operating expenses?
The current quarterly operating expenses of EW is $697.20 M
What is the all time high quarterly operating expenses for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly total operating expenses is $774.90 M
What is Edwards Lifesciences quarterly operating expenses year-on-year change?
Over the past year, EW quarterly total operating expenses has changed by -$12.70 M (-1.79%)